News

The company has ended the trial as recommended by its independent data monitoring committee (IDMC) which observed an imbalance in deaths between the two treatment arms of the

In addition, the board of directors appointed Dr Spigelman as chairman of the company’s clinical oversight committee as well as a member of the compensation committee. Dr Spigelman

Stereotaxis’s magnetically steerable radiofrequency guidewire is said to be designed to ablate through chronic total occlusions (CTO) in peripheral arteries. Its Niobe magnetic navigation system directs the guidewire’s

Ms Pero will lead the expansion of the Global Alliance for TB Drug Development’s (TB Alliance) staff and internal operations as it advances the new tuberculosis (TB) drug

The companies have signed an agreement that enables Medrad to sell CADstream in the UK, Germany and Italy. Under the agreement, Confirma will install, train and support all

Similar to the 385K and 4x72K NimbleGen microarrays, the new 12x135K arrays display high specificity, high sensitivity, and excellent reproducibility, the company said. For researchers interested in studying

The Named Patient Access Program (NPAP) is a compassionate use drug supply program under which medical practitioners can legally supply investigational drugs to their eligible patients. Under this

Under the grant, Maxygen will continue development of ParallelaVax technology for rapid generation of vaccine candidates and high-throughput testing in animal models. The work will be done in

The waiver applies to all 14 drugs that the company currently tests for in addition to two different cut-off levels for its opiate and cocaine tests. Clinical Laboratory